Edition:
India

GW Pharmaceuticals PLC (GWPH.OQ)

GWPH.OQ on NASDAQ Stock Exchange Global Market

132.55USD
15 Aug 2018
Change (% chg)

-- (--)
Prev Close
$132.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
106,775
52-wk High
$164.58
52-wk Low
$96.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 2.38 -0.185
Dec 5.73 -0.150
FY 2017 Sep '17 2.14 -0.136
Jun '17 2.41 -0.133
Mar '17 1.63 -0.113
Dec 2.06 -0.052
FY 2016 Sep '16 1.67 -0.057
Jun '16 2.33 -0.046
Mar '16 2.65 -0.064
Dec 3.67 -0.068
 
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 2.98 3.93 2.00 --
Quarter Ending Sep-18 5 4.12 9.00 2.00 5.60
Year Ending Sep-18 4 17.05 18.04 16.54 73.23
Year Ending Sep-19 4 156.35 218.92 129.40 343.03
Earnings (per share)
Quarter Ending Jun-18 1 -2.67 -2.67 -2.67 --
Quarter Ending Sep-18 1 -2.51 -2.51 -2.51 -1.31
Year Ending Sep-18 2 -7.74 -6.13 -9.34 -4.92
Year Ending Sep-19 1 -3.64 -3.64 -3.64 -2.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -63.86 -27.70 -19.02
EPS (TTM) % -30.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for GW Pharmaceuticals PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.20 -1.32 99 --
13 Week 7.71 2.46 99 --
26 Week -5.47 -12.65 93 --
52 Week -17.39 -29.98 74 --
YTD -1.61 -13.59 85 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.88%
# of Holders: 304
Total Shares Held: 21,904,797
3 Mo. Net Change: -558,857
# New Positions: 83
# Closed Positions: 17
# Increased Positions: 168
# Reduced Positions: 74
# Net Buyers: 94
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.